Versartis Trial in Children to Assess Long-Acting Growth Hormone

Inclusion Criteria: * Chronological Age ≥ 3.0 years and ≤ 11.0 * Diagnosis of GHD as documented by GH stimulation test * Below average height SDS at screening * Appropriate weight for Stature * Decreased IGF-I SDS at screening * Delayed bone age * Normal thyroid function test results at screening visit * Legally authorized representative informed consent. Exclusion Criteria: * Prior treatment with any growth promoting agent * Documented history of, or current, significant disease * Chromosomal aneuploidy, significant gene mutations * Diagnosis of Attention Deficit Hyperactivity Disorder * Daily use of anti-inflammatory doses of glucocorticoid * Prior history of leukemia, lymphoma, sarcoma or cancer * Known allergy to constituents of the study drug formulation * Abnormal ocular findings at screening * Significant abnormality in screening laboratory studies